The apoptosis-inducing activity of the two protein phosphatase inhibitors, tautomycin and thyrsiferyl 23-acetate, is not due to the inhibition of protein phosphatases PP1 and PP2A (Review)

International Journal of Molecular Medicine

Volumn 4, Issue 4, 1999, Pages 395-401

  Kikuchi, Kunimi ^a   Shima, Hiroshi ^a   Mitsuhashi, Shinya ^a   Suzuki, Minoru ^a   Oikawa, Hideaki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Apoptosis inducing activity; Phosphatase inhibitors; Tautomycin; Thyrsiferyl 23 acetate

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN INHIBITOR; TAUTOMYCIN; THYRSIFERYL 23 ACETATE; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; ENZYME INHIBITOR; PYRAN DERIVATIVE; SPIRO COMPOUND; THYRSIFERYL 23-ACETATE;

APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL DEATH; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; IC50; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; ANIMAL; DRUG ANTAGONISM; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; APOPTOSIS; ENZYME INHIBITORS; HUMANS; PHOSPHOPROTEIN PHOSPHATASE; PYRANS; SIGNAL TRANSDUCTION; SPIRO COMPOUNDS;

EID: 0033209692     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.4.4.395     Document Type: Article

References (26)

1. Fujiki H and Suganuma M: Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv Cancer Res 61: 143-194, 1993.
2. MacKintosh C and MacKintosh RW: Inhibitors of eukaryotic protein (serine/threonine) phosphatases: environmental toxins prove useful in the laboratory. Adv Prot Phosphatases 8: 343-354, 1994.
3. Fujiki H, Sueoka E, Komori A and Suganuma M: Tumor promoter and TNF - A gene expression by the okadaic acid class tumor promoters. Environ Carcinog Rev 15c: 1-40, 1997.
4. Matsuzawa S, Suzuki T, Suzuki M, Matsuda A, Kawamura T, Mizuno Y and Kikuchi K: Thyrsiferyl 23-acetate is a novel specific inhibitor of protein phosphatase PP2A. FEBS Lett 356: 272-274, 1994.
5. Matsuzawa S, Kawamura T, Mitsuhashi S, Suzuki T, Matsuo Y, Suzuki M, Mizuno Y and Kikuchi K: Thyrsiferyl 23-acetate and its derivatives induce apoptosis in various T- and B-leukemia cells. Bioorg Med Chem 7: 381-387, 1999.
6. Kawamura T, Matsuzawa S, Mizuno Y, Kikuchi K, Oikawa H, Oikawa M, Ubukata M and Ichihara A: Different moieties of tautomycin involved in protein phosphatase inhibition and induction of apoptosis. Biochem Pharmacol 55: 995-1003, 1998.
7. Mitsuhashi S, Shima H, Kawamura T, Kikuchi K, Oikawa M, Ichihara H and Oikawa H: The spiroketal compounds containing a benzyloxymethyl moiety at C8 position showed the most potent apoptosis-inducing activity. Bioorg Med Chem Lett 9: 2007- 2012, 1999.
8. Suzuki T, Suzuki M, Furusaki A, Matsumoto T, Kurosawa E, Kato A and Imanaka Y: Teurilene and thyrsiferyl-23-acetate, meso and remarkably cytotoxic compounds from the marine red alga Laurecia obtusa (Hudson) Lamouroux. Tetrahedron Lett 26: 1329-1332, 1985.
9. Cheng XC, Kihara T, Kusakabe H, Magae J, Kobayashi Y, Fang RP, Ni ZF, Shen YC, Ko K, Yamaguchi I and Isono K: A new antibiotic, tautomycin. J Antibiot 40: 907-909, 1987.
10. Ubukata M, Cheng XC and Isono K: The structure of tautomycin, a regulator of eukaryotic cell growth. J Chem Soc Chem Commun : 244-246, 1990.
11. Cheng XC, Ubukata M and Isono K: The structure of tautomycin, a dialkylmaleic anhydride antibiotic. J Antibiot 43: 809-819, 1990.
12. MacKintosh C and Klumpp S: Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A. FEBS Lett 277: 137-140, 1990.
13. Hori M, Magae J, Han YG, Hartshorne DJ and Karaki H: A novel protein phosphatase inhibitor, tautomycin. Effect on smooth muscle. FEBS Lett 285: 145-148, 1991.
14. Suganuma M, Okabe S, Sueoka E, Nishiwaki R, Komori A, Uda N, Isono K and Fujiki H: Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach. J Cancer Res Clin Oncol 121:621-627, 1995.
15. Hescheler J, Mieskes G, Ruegg JC, Takai A and Trautwein W: Effects of a protein phosphatase inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes. Pflugers Arch 412: 248-252, 1988.
16. Inomata M, Saijo N, Kawashima K, Kaneko A, Fujiwara Y, Kunikane H and Tanaka Y: Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid. J Cancer Res Clin Oncol 121: 729-738, 1995.
17. Boe R, Gjertsen BT, Vintermyr OK, Houge G, Lanotte M and Doskeland SO: The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp Cell Res 195: 237-246, 1991.
18. Oikawa M, Ueno T, Oikawa H and Ichihara A: Total synthesis of tautomycin. J Org Chem 60: 5048-5068, 1995.
19. Cohen P, Klumpp S and Schelling DL: An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett 250: 596-600, 1989.
20. Honkanen RE, Dukelow M, Zwiller J, Moore RE, Khatra BS and Boynton AL: Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases. Mol Pharmacol 40: 577-583, 1991.
21. Vaux DL and Strasser A: The molecular biology of apoptosis. Proc Natl Acad Sei USA 93: 2239-2244, 1996.
22. Simon HU and Blaser K: Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol Today 16: 53-55, 1995.
23. Matsuzawa S, Tamura T, Mizuno Y, Kobayashi S, Okuyama H, Tsukitani Y, Uemura D and Kikuchi K: Increase in potential activities of protein phosphatases PP1 and PP2A in lymphoid tissues of autoimmune MRL/MpJ-lpr/Ipr mice. J Biochem 111: 472-477, 1992.
24. Singh SB, Zink DL, Liesch JM, Goetz MA, Jenkins RG, Nallin-Omstead M, Silverman KC, Bills GF, Mosley RT, Gibbs JB, Albers-Schonberg G and Lingham RB: Isolation and structure of chaetomellic acids A and B from Chaetommela acutiseta farnesyl pyrophosphate mimic inhibitors of Ras farnesyl-protein transferase. Tetrahedron 49: 5917-5926, 1993.
25. Nishiyama U, Ubukata M, Magae J, Kataoka T, Erdodi F, Hartshorne DJ, Isono K, Nagai K and Osada H: Structureactivity relationship within a series of degradation products of tautomycin. Biosci Biotechnol Biochem 60: 103-107, 1996.
26. Sugiyama Y, Ohtani I, Isobe M, Takai A, Ubukata M and Isono K: Molecular shape analysis and activity of tautomycin, a protein phosphatase inhibitor. Bioorg Med Chem 6: 3-8, 1996.